JSM2023
Back to all people

Yu Mao Chen

Bristol Myers Squibb
1 appearance in the program

Sessions & presentations

Contributed Poster Presentations: Biopharmaceutical Section
Presentation: 15 Determining Optimal Cutoff for Unvalidated Composite Endpoints in Cardiovascular Disease Trials
Contributed Posters · Mon, Aug 7 , 10:30 AM
First Author
↑